Thomas Grünewald

1.5k total citations
42 papers, 641 citations indexed

About

Thomas Grünewald is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Thomas Grünewald has authored 42 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Thomas Grünewald's work include Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Thomas Grünewald is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Thomas Grünewald collaborates with scholars based in Germany, United Kingdom and United States. Thomas Grünewald's co-authors include Timo Wolf, Oliver T. Keppler, Stephan Becker, Kai Zacharowski, Christoph Stephan, Thomas J. Vogl, Volkhard A. J. Kempf, Gerrit Kann, Philipp de Leuw and Arne Broch Brantsæter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The American Journal of Gastroenterology.

In The Last Decade

Thomas Grünewald

39 papers receiving 606 citations

Peers

Thomas Grünewald

EMS

EPIDE

F. Rosmini Italy

Marie‐Louise A. Heijnen Netherlands

Raita Tamaki Japan

John Mair-Jenkins United Kingdom

Hana Hakim United States

Santtu Heinonen Finland

Basel Al Raiy United States

Marian G.J. van Kraaij Netherlands

María Saavedra-Campos United Kingdom

Sana Chams United States

F. Rosmini Italy

Thomas Grünewald

248 ×0.6

123 ×0.6

EMS

191 ×1.5

EPIDE

5 ×0.1

39 ×0.7

Citations per year, relative to Thomas Grünewald Thomas Grünewald (= 1×) peers F. Rosmini

Countries citing papers authored by Thomas Grünewald

Since Specialization

Citations

This map shows the geographic impact of Thomas Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Grünewald more than expected).

Fields of papers citing papers by Thomas Grünewald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Grünewald. The network helps show where Thomas Grünewald may publish in the future.

Co-authorship network of co-authors of Thomas Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Grünewald. A scholar is included among the top collaborators of Thomas Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Grünewald. Thomas Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fallah, Mosoka, et al.. (2023). Feasibility of digital contact tracing in low-income settings – pilot trial for a location-based DCT app. BMC Public Health. 23(1). 146–146. 3 indexed citations

Rein, Susanne, et al.. (2023). Microbiologic Analysis of Hand Infections: A Prospective Study. Surgical Infections. 24(7). 625–631.

Luo, Ji, Andor Krizsan, Thomas Grünewald, et al.. (2022). Evaluation of S- and M-Proteins Expressed in Escherichia coli and HEK Cells for Serological Detection of Antibodies in Response to SARS-CoV-2 Infections and mRNA-Based Vaccinations. Pathogens. 11(12). 1515–1515. 3 indexed citations

Luo, Ji, Andor Krizsan, Daniela Volke, et al.. (2022). Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections. Virology Journal. 19(1). 50–50. 24 indexed citations

Hönemann, Mario, Christian Lück, Melanie Maier, et al.. (2021). Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays. Diagnostic Microbiology and Infectious Disease. 100(4). 115382–115382. 3 indexed citations

Uyeki, Timothy M., Aneesh K. Mehta, Richard T. Davey, et al.. (2016). Clinical Management of Ebola Virus Disease in the United States and Europe. New England Journal of Medicine. 374(7). 636–646. 225 indexed citations

Grünewald, Thomas & B. Ruf. (2012). Muskuloskelettale Infektionen im Zeitalter multiresistenter Erreger. Der Unfallchirurg. 115(6). 503–510. 3 indexed citations

Pliquett, Rainer U., et al.. (2011). Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients. European Journal of Clinical Microbiology & Infectious Diseases. 30(12). 1557–1560. 5 indexed citations

Gottschalk, René, et al.. (2009). Aufgaben und Funktion der Ständigen Arbeitsgemeinschaft der Kompetenz- und Behandlungszentren für hochkontagiöse, lebensbedrohliche Erkrankungen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 52(2). 214–218. 7 indexed citations

10.

Grünewald, Thomas, Elizabeth Davies, V. Mak, et al.. (2007). Does deprivation of area of residence influence the incidence, tumour site or T stage of cutaneous malignant melanoma? A population-based and clinical database study. Clinical and Experimental Dermatology. 32(5). 574–577. 3 indexed citations

11.

Doherty, Michael, K. Acland, Eduardo Calonje, et al.. (2004). Pattern of disease recurrence in malignant melanoma following a positive sentinel node biopsy. British Journal of Dermatology. 151. 14–14. 3 indexed citations

12.

Schürmann, Dirk, Frank Bergmann, Helmut Albrecht, et al.. (2001). Twice-weekly Pyrimethamine–sulfadoxine Effectively Prevents Pneumocystis carinii Pneumonia Relapse and Toxoplasmic Encephalitis in Patients with AIDS. Journal of Infection. 42(1). 8–15. 16 indexed citations

13.

Grünewald, Thomas, et al.. (2001). Nosokomiale Epidemiologie und Transmission der Clostridium-difficile-Infektion. DMW - Deutsche Medizinische Wochenschrift. 126(18). 519–522. 1 indexed citations

14.

Grünewald, Thomas, et al.. (2000). Coxitis tuberculosa Fallbericht und chirurgische Behandlung. Der Unfallchirurg. 103(5). 401–404. 2 indexed citations

15.

Dormann, Arno J., et al.. (1999). A Single Dose of Ceftriaxone Administered 30 Minutes Before Percutaneous Endoscopic Gastrostomy Significantly Reduces Local and Systemic Infective Complications. The American Journal of Gastroenterology. 94(11). 3220–3224. 58 indexed citations

16.

Grünewald, Thomas, Johannes Lampe, Benedikt Weißbrich, & Heinz Reichmann. (1998). A 35-year-old bricklayer with hemimyoclonic jerks. The Lancet. 351(9120). 1926–1926. 6 indexed citations

17.

Knollmann, Friedrich, Thomas Grünewald, Andreas Adler, et al.. (1997). Intestinal disease in acquired immunodeficiency: evaluation by CT. European Radiology. 7(9). 1419–1429. 5 indexed citations

18.

Grünewald, Thomas, et al.. (1997). Selective Expansion of γδ T Cells among Liver-Derived Lymphocytes of AIDS Patients with DisseminatedMycobacterium aviumComplex Infection. Clinical Immunology and Immunopathology. 85(2). 151–157. 4 indexed citations

19.

Buttgereit, Frank, et al.. (1997). Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases. Clinical Rheumatology. 16(6). 562–569. 10 indexed citations

20.

Schürmann, Dirk, et al.. (1995). Intensive treatment of AIDS‐related non‐Hodgkin's lymphomas with the MACOP‐B protocol. European Journal Of Haematology. 54(2). 73–77. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact